Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25636388 | 0.86 | ACHE (0.31) | — | |
| SCHEMBL4760088 | 0.84 | — | — | |
| SCHEMBL1239094 | 0.82 | TSHR (0.33) | — | |
| SCHEMBL3838323 | 0.82 | — | — | |
| SCHEMBL12203614 | 0.82 | — | — | |
| SCHEMBL10155990 | 0.80 | — | — | |
| SCHEMBL10044207 | 0.80 | TP53 (0.33) | — | |
| SCHEMBL1023192 | 0.79 | CA1 (0.33) | CA1CA2CA9 | |
| SCHEMBL3844389 | 0.78 | — | — | |
| SCHEMBL14444699 | 0.78 | ADRB2 (0.36) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008048947-A2 | APPARATUS FOR AND RELATED METHOD OF INHIBITING LEWIS ACID DEGRADATION IN A VAPORIZER | ABBOTT LABORATORIES (US) | 2008-04-24 | — | — | WO | disclosed |
| US-20080087283-A1 | APPARATUS FOR AND RELATED METHOD OF INHIBITING LEWIS ACID DEGRADATION IN A VAPORIZER | ABBOTT LABORATORIES (US) | 2008-04-17 | — | — | US | disclosed |
| US-20060148906-A1 | Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid | BIENIARZ CHRISTOPHER | 2006-07-06 | — | — | US | disclosed |
| EP-1114641-B1 | Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid | ABBOTT LAB (US) | 2006-03-22 | — | — | EP | disclosed |
| US-20040048932-A1 | Fluoroether compositions and methods for inhibiting their degradation in the presnce of a lewis acid | BIENIARZ CHRISTOPHER (US) | 2004-03-11 | — | — | US | disclosed |
| US-6677492-B2 | SEVOFLURANE | ABBOTT LABORATORIES | 2004-01-13 | — | — | US | disclosed |
| US-20030130359-A1 | Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid | ABBVIE INC. | 2003-07-10 | — | — | US | disclosed |
| US-6444859-B2 | ADDING TO THE FLUOROETHER COMPOUND SELECTED FROM EVOFLURANE, ENFLURANE, ISOFLURANE, METHOXYFLURANE AND DESFLURANE AN EFFECTIVE STABILIZING AMOUNT OF A LEWIS ACID INHIBITOR TO PREVENT THE DEGRADATION OF FLUOROETHER | ABBOTT LABORATORIES | 2002-09-03 | — | — | US | disclosed |
| US-20020016373-A1 | Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid | ABBVIE INC. | 2002-02-07 | — | — | US | disclosed |
| US-6288127-B1 | ADDING LEWIS ACID INHIBITOR | ABBOTT LABORATORIES & CENTRAL GLASS CO LTD | 2001-09-11 | — | — | US | disclosed |
| EP-1114641-A2 | Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid | Abbott Laboratories (US) | 2001-07-11 | — | — | EP | disclosed |
| EP-0967975-B1 | FLUOROETHER COMPOSITIONS AND METHODS FOR INHIBITING THEIR DEGRADATION IN THE PRESENCE OF A LEWIS ACID | ABBOTT LAB (US) | 2001-06-13 | — | — | EP | disclosed |
| EP-0967975-A1 | FLUOROETHER COMPOSITIONS AND METHODS FOR INHIBITING THEIR DEGRADATION IN THE PRESENCE OF A LEWIS ACID | Abbott Laboratories (US) | 2000-01-05 | — | — | EP | disclosed |
| US-5990176-A | ANESTHETIC COMPOSITION OF SEVOFLURANE AND A STABILIZING AMOUNT OF A LEWIS ACID INHIBITOR SELECTED FROM THE GROUP CONSISTING OF WATER, BUTYLATED HYDROXYTOLUENE, METHYLPARABEN, PROPYLPARABEN, PROPOFOL, AND THYMOL | ABBOTT LABORATORIES (US) | 1999-11-23 | — | — | US | disclosed |
| WO-1998032430-A1 | FLUOROETHER COMPOSITIONS AND METHODS FOR INHIBITING THEIR DEGRADATION IN THE PRESENCE OF A LEWIS ACID | ABBOTT LABORATORIES (US) | 1998-07-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040048932-A1 | Fluoroether compositions and methods for inhibiting their degradation in the presnce of a lewis acid | CA1, MLLT3, MME | CA1 1/4885CA2 119/4885CA9 46/4885 |
| US-20030130359-A1 | Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid | CA1, MLLT3, LCT | CA1 1/4885CA2 87/4885CA9 57/4885 |
| US-20020016373-A1 | Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid | CA1, MLLT3, LCT | CA1 1/4885CA2 87/4885CA9 57/4885 |
| US-20060148906-A1 | Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid | CA1, MLLT3, LCT | CA1 1/4885CA2 87/4885CA9 57/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.